Almudena Gómez-Hernández Selected Research

Almudena Gómez-Hernández Research Topics

Disease

10	Atherosclerosis 01/2024 - 01/2002
8	Obesity 04/2024 - 01/2013
8	Insulin Resistance 01/2023 - 04/2009
7	Inflammation (Inflammations) 01/2023 - 08/2005
7	Atherosclerotic Plaque (Atheroma) 12/2022 - 02/2004
6	Carotid Artery Diseases 01/2024 - 02/2004
4	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2020
4	Carotid Stenosis (Carotid Artery Stenosis) 07/2006 - 02/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2016
2	Disease Progression 01/2024 - 07/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 01/2023
2	Rupture 01/2018 - 07/2006
2	Glucose Intolerance 11/2016 - 01/2016
2	Hyperplasia 07/2015 - 04/2009
1	Alcoholic Fatty Liver 01/2023
1	Ischemia 01/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023
1	Peripheral Arterial Disease 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Body Weight (Weight, Body) 01/2018
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2018
1	Metabolic Diseases (Metabolic Disease) 11/2016
1	Hypercholesterolemia 01/2016
1	Hypertriglyceridemia 01/2016
1	Hypertension (High Blood Pressure) 07/2014
1	Weight Gain 01/2013
1	Necrosis 01/2009
1	Acute Coronary Syndrome 07/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2008

Drug/Important Bio-Agent (IBA)

9	Insulin ReceptorIBA 01/2023 - 04/2009
7	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2020
6	Insulin (Novolin)FDA Link 01/2023 - 04/2009
6	NF-kappa B (NF-kB)IBA 01/2009 - 02/2004
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
5	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2012
4	ApolipoproteinsIBA 01/2023 - 01/2016
4	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2009
4	Atorvastatin (Lipitor)FDA Link 07/2008 - 01/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 04/2009
3	Insulin-Like PeptidesIBA 01/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
3	Dinoprostone (PGE2)FDA Link 07/2008 - 01/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2006 - 01/2002
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2023 - 01/2018
2	oxidized low density lipoproteinIBA 01/2023 - 01/2018
2	LipidsIBA 12/2022 - 01/2013
2	Insulin-Like Growth Factor I (IGF-1)IBA 07/2015 - 04/2009
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2009 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2009 - 01/2006
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2009 - 01/2007
2	Leukotriene B4IBA 01/2009 - 07/2008
2	Prostaglandin-E SynthasesIBA 07/2006 - 01/2006
1	MyokinesIBA 04/2024
1	Amino Acids FDA Link 04/2024
1	Thyroid HormonesIBA 04/2024
1	proteoliposomesIBA 01/2023
1	AlginatesIBA 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	HydrogelsIBA 01/2023
1	Syndecan-4IBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	Sulfates (Sulfates, Inorganic)IBA 12/2022
1	Polysaccharides (Glycans)IBA 12/2022
1	rhamnanIBA 12/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2022
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	GlycogenIBA 12/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	PalmitatesIBA 06/2015
1	Oleic Acid (Oleate)IBA 06/2015
1	Bromodeoxyuridine (BrdU)IBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014
1	CytokinesIBA 01/2013
1	AdipokinesIBA 03/2012
1	Chemotactic FactorsIBA 01/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2009
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2009
1	EnzymesIBA 07/2008
1	GelatinIBA 07/2008
1	ImmunosorbentsIBA 07/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2008
1	licofeloneIBA 01/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2007
1	rofecoxib (Vioxx)FDA Link 01/2007
1	Prostaglandins EIBA 07/2006
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 07/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006
1	dicyclohexyl 2,3-epoxysuccinate (Ep-1)IBA 01/2006
1	Fas Ligand Protein (Fas Ligand)IBA 02/2004

Therapy/Procedure

6	Therapeutics 01/2023 - 07/2008
1	Injections 01/2023